rs13689

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP2BA1

This summary comes from the ClinGen Evidence Repository: The NM_004360.5(CDH1):c.*1120T>C variant has an allele frequency of 0.21013 (21%, 730/3474 alleles, 79 homozygotes) in the African subpopulation of the gnomAD v2.1.1 cohort (BA1; BP2). Therefore, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the CDH1 Variant Curation Expert Panel (Variant Interpretation Guidelines Version 3.1): BA1, BP2. LINK:https://erepo.genome.network/evrepo/ui/classification/CA10647981/MONDO:0007648/007

Frequency

Genomes: 𝑓 0.18 ( 2356 hom., cov: 32)
Exomes 𝑓: 0.17 ( 1398 hom. )

Consequence

CDH1
NM_004360.5 3_prime_UTR

Scores

2

Clinical Significance

Benign reviewed by expert panel B:3

Conservation

PhyloP100: -0.682

Publications

27 publications found
Variant links:
Genes affected
CDH1 (HGNC:1748): (cadherin 1) This gene encodes a classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion protein is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function of this gene is thought to contribute to cancer progression by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. This gene is present in a gene cluster with other members of the cadherin family on chromosome 16. [provided by RefSeq, Nov 2015]
CDH1 Gene-Disease associations (from GenCC):
  • blepharocheilodontic syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • CDH1-related diffuse gastric and lobular breast cancer syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • hereditary diffuse gastric adenocarcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • cleft soft palate
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • orofacial cleft 3
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • blepharocheilodontic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004360.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH1
NM_004360.5
MANE Select
c.*1120T>C
3_prime_UTR
Exon 16 of 16NP_004351.1A0A0U2ZQU7
CDH1
NM_001317184.2
c.*1120T>C
3_prime_UTR
Exon 15 of 15NP_001304113.1P12830-2
CDH1
NM_001317185.2
c.*1120T>C
3_prime_UTR
Exon 16 of 16NP_001304114.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH1
ENST00000261769.10
TSL:1 MANE Select
c.*1120T>C
3_prime_UTR
Exon 16 of 16ENSP00000261769.4P12830-1
CDH1
ENST00000566612.5
TSL:1
n.*2009T>C
non_coding_transcript_exon
Exon 15 of 15ENSP00000454782.1H3BNC6
CDH1
ENST00000566612.5
TSL:1
n.*2009T>C
3_prime_UTR
Exon 15 of 15ENSP00000454782.1H3BNC6

Frequencies

GnomAD3 genomes
AF:
0.178
AC:
27019
AN:
152114
Hom.:
2351
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.152
Gnomad AMI
AF:
0.116
Gnomad AMR
AF:
0.180
Gnomad ASJ
AF:
0.184
Gnomad EAS
AF:
0.156
Gnomad SAS
AF:
0.110
Gnomad FIN
AF:
0.212
Gnomad MID
AF:
0.244
Gnomad NFE
AF:
0.194
Gnomad OTH
AF:
0.161
GnomAD4 exome
AF:
0.170
AC:
15218
AN:
89672
Hom.:
1398
Cov.:
0
AF XY:
0.168
AC XY:
7101
AN XY:
42196
show subpopulations
African (AFR)
AF:
0.159
AC:
618
AN:
3878
American (AMR)
AF:
0.175
AC:
515
AN:
2950
Ashkenazi Jewish (ASJ)
AF:
0.174
AC:
884
AN:
5078
East Asian (EAS)
AF:
0.128
AC:
1424
AN:
11102
South Asian (SAS)
AF:
0.0896
AC:
223
AN:
2488
European-Finnish (FIN)
AF:
0.190
AC:
177
AN:
932
Middle Eastern (MID)
AF:
0.168
AC:
86
AN:
512
European-Non Finnish (NFE)
AF:
0.181
AC:
10060
AN:
55640
Other (OTH)
AF:
0.174
AC:
1231
AN:
7092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
630
1260
1889
2519
3149
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.178
AC:
27063
AN:
152232
Hom.:
2356
Cov.:
32
AF XY:
0.177
AC XY:
13165
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.153
AC:
6338
AN:
41544
American (AMR)
AF:
0.179
AC:
2742
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.184
AC:
639
AN:
3470
East Asian (EAS)
AF:
0.156
AC:
808
AN:
5180
South Asian (SAS)
AF:
0.111
AC:
535
AN:
4832
European-Finnish (FIN)
AF:
0.212
AC:
2248
AN:
10594
Middle Eastern (MID)
AF:
0.241
AC:
71
AN:
294
European-Non Finnish (NFE)
AF:
0.194
AC:
13225
AN:
68008
Other (OTH)
AF:
0.167
AC:
351
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1169
2339
3508
4678
5847
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
292
584
876
1168
1460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.185
Hom.:
1271
Bravo
AF:
0.179
Asia WGS
AF:
0.150
AC:
519
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
CDH1-related diffuse gastric and lobular breast cancer syndrome (1)
-
-
1
Hereditary diffuse gastric adenocarcinoma (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.36
DANN
Benign
0.52
PhyloP100
-0.68
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13689; hg19: chr16-68868522; COSMIC: COSV55740499; COSMIC: COSV55740499; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.